Medical Oncologist
CION Cancer Clinics
Conversion chemotherapy: shrinking liver spread so surgery becomes possible | CION Cancer Clinics
Conversion chemotherapy is treatment given to shrink liver metastases that are too large or too many to remove, so that surgery becomes possible. If it works, the operation can be planned with curative intent. It works for only some people, and the decision to operate rests with a tumour board that includes a liver surgeon. This page explains who it is for, how it runs and why timing matters. At CION Cancer Clinics, a multidisciplinary team plans colon cancer treatment for your stage, from surgery to chemotherapy and follow-up.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is conversion chemotherapy for liver metastases?
- Who is conversion chemotherapy for, and who is it not for?
- Which drugs are used for conversion chemotherapy?
- What happens during conversion chemotherapy?
- Why should surgery not wait once the liver is operable?
- What this page cannot tell you
- Common questions about conversion chemotherapy
The short answer
What is conversion chemotherapy for liver metastases?
It is chemotherapy, usually with a targeted drug added, given to someone whose liver spread cannot be removed today but might be removable if it shrinks. The aim is specific: to turn an inoperable liver into an operable one. If that happens, liver surgery becomes possible, and for some people the cancer becomes potentially curable.
How it differs from other chemotherapy before surgery
When liver spots can already be removed, chemotherapy is sometimes given before and after the operation to deal with cancer cells too small to see. That is a different plan. Conversion chemotherapy starts before anyone knows whether surgery will happen. It is chosen to shrink tumours as much as possible, so the combinations are often stronger. Our page on chemotherapy before surgery covers the other situation.
Why the liver surgeon is involved from the first day
A liver surgeon should see the scans before the first cycle and at every review. Only a surgeon can say what small enough means for your liver. Without that, the moment when surgery became possible can pass unnoticed while chemotherapy simply carries on. Read who is eligible for liver surgery for the questions they ask.
Ask at the start: is the goal of my chemotherapy to make surgery possible, or to control the cancer?Who it suits
Who is conversion chemotherapy for, and who is it not for?
It is offered to a fairly specific group. Knowing which group you are in helps you understand what your treatment is aiming for.
Liver spread that is too extensive today
All the cancer outside the bowel is in the liver, but there are too many spots, they sit too close to major blood vessels, or too little healthy liver would be left. Shrinking them may change the answer.
Liver spread with a few spots elsewhere
A small number of lung spots, for example, that could also be removed or treated later. The tumour board judges whether the whole picture could become operable.
Not for widespread spread
If the cancer is in many organs, surgery will not be offered however well chemotherapy works. Chemotherapy is still valuable here. Its goal is control and comfort, and the plan is built differently.
Also usually not for
- Spread mainly in the lining of the abdomen
- Spread to the bones or brain
Not for someone too frail for major surgery
Conversion only makes sense if the operation could actually happen. A person too unwell for liver surgery is better served by gentler treatment aimed at keeping the cancer in check.
Not sure whether this applies to you?
Ask an oncologistMatching drugs to the tumour
Which drugs are used for conversion chemotherapy?
Tumour test result
What is usually used
RAS and BRAF normal, tumour on the left side
Two chemotherapy drugs with an antibody such as cetuximab
RAS changed, or tumour on the right side
Two or three chemotherapy drugs with bevacizumab
BRAF V600E change
Often a stronger three-drug combination, as this type tends to grow fast
MSI-high or dMMR
Immunotherapy may be weighed first, as it can work well in this group
From first cycle to surgery
What happens during conversion chemotherapy?
-
Tests on the tumour come first
The tumour is tested for RAS, BRAF and MSI, gene changes that decide which drugs will work. Our page on why RAS and BRAF are tested first explains this. A baseline CT and usually a liver MRI record exactly where every spot is.
-
Treatment in cycles at CION
Chemotherapy is given in cycles, each followed by a rest so the body can recover. The targeted drug is given alongside. Details of common combinations are on the FOLFOX regimen page.
-
Scans after every few cycles
Usually after about two to three months, the scans are repeated. The tumour board, with the liver surgeon, compares them with the baseline images, spot by spot.
-
The decision point
If the spots have shrunk enough, surgery is planned as soon as it is safe. If they are shrinking but not enough yet, treatment continues and is checked again. If they grow, the plan changes.
-
A pause before the operation
Chemotherapy stops a few weeks before surgery so the liver and blood counts recover. Bevacizumab needs a longer gap because it slows wound healing; see surgery while on bevacizumab.
-
Surgery, then more chemotherapy
CION's surgical oncologists plan the liver operation, and it is carried out at an accredited partner hospital. More chemotherapy is usually given afterwards at CION to complete the course.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Why timing matters
Why should surgery not wait once the liver is operable?
Once the tumours have shrunk enough, more chemotherapy does not make the operation better. It can make it harder. The usual advice is to operate at the first point the liver surgeon says it can be done safely.
Longer courses can harm the liver
Oxaliplatin can congest the tiny blood vessels inside the liver, sometimes called a blue liver. Irinotecan can cause fatty inflammation. Both make the liver bleed more during surgery and recover more slowly afterwards. The risk grows with each extra cycle, so there is no gain in continuing past the point where surgery became possible.
When spots vanish on the scan
Sometimes a spot shrinks so much it can no longer be seen. That is partly good news. But cancer cells often remain where the spot used to be. The surgeon needs to know where each one was, so the scans from before treatment are kept and an MRI is repeated before the operation. This is one more reason surgery is planned before spots shrink out of sight.
Being straight with you
What this page cannot tell you
It cannot tell you whether chemotherapy will make your liver operable. Only some people respond enough, and nobody can predict in advance who they will be. Your scans after the first few cycles are the honest answer, and the tumour board will share it with you.
If surgery does not become possible
The treatment was not wasted. The same chemotherapy is still keeping the cancer in check, and other options remain, such as ablation for a few small spots, a change of drugs or a lighter maintenance plan. The goal shifts to living well for as long as possible.
Who this does not apply to
This page is about liver spread from colon cancer. Rectal cancer spread follows similar thinking, but radiation and timing differ, so see the rectal cancer pages. It does not apply when spread is mainly in the lining of the abdomen, which has its own surgical pathway.
Bring every scan disc and report to each review. The comparison with the first scan is what the decision rests on.Questions we are asked
Common questions about conversion chemotherapy
How many people become operable after conversion chemotherapy?
Only some. The share depends heavily on how much of the liver is involved at the start, the tumour's gene results and the drugs used. Your oncologist can say whether conversion is realistic in your situation, but nobody can predict your own response before treatment begins.
How long does conversion chemotherapy last?
Scans are usually repeated after about two to three months. If the liver is operable by then, surgery follows after a short break. If the spots are still shrinking, treatment may continue a little longer with regular checks. Long open-ended courses before surgery are avoided.
Is it stronger than ordinary chemotherapy?
Often it is. It may combine two or three chemotherapy drugs with a targeted drug, aiming for the most shrinkage possible. That can mean more side effects. The team weighs this against your fitness, because you need to be well enough for surgery afterwards.
What side effects should I expect?
They depend on the drugs. Common ones are tiredness, diarrhoea, mouth sores, numbness or tingling in the fingers, a low white cell count, and a skin rash with cetuximab. Most are managed at your treatment visits. Report fever or severe diarrhoea to the team the same day.
If the spots disappear on the scan, can I skip surgery?
Usually not. A spot that has vanished on the scan often still holds cancer cells. The surgeon will normally remove those areas, or watch them very closely if removal is not practical. This is why the scans from before treatment and a fresh MRI matter so much.
Will I need chemotherapy after the liver operation?
Usually yes, to complete the planned course. The total amount given before and after surgery is agreed by the tumour board. Treatment after the operation is given at CION once you have recovered enough, and your surgeon and oncologist agree on the timing.
Can the bowel tumour stay in place during treatment?
Often yes, if it is not bleeding heavily or blocking the bowel. Some people have the bowel tumour removed first, while others have both dealt with later. The order depends on your symptoms and on the tumour board's view of which tumour carries more risk.
Who decides whether I am operable after treatment?
The tumour board, with a liver surgeon comparing the new scans against the old ones. If no liver surgeon has seen your scans, ask for that review. CION can arrange it through the helpline, and the operation itself is carried out at an accredited partner hospital.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Colorectal Cancer Chemotherapy
- American Cancer Society — Colorectal Cancer Targeted Therapy
- National Cancer Institute — Colon Cancer Treatment (PDQ), Health Professional Version
- ESMO — Colorectal Cancer: A Guide for Patients
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Who is eligible for liver metastasis surgery?The four questions the liver surgeon asks at every reviewWhen liver metastases are curable by surgeryWhy reaching surgery matters so much in liver spreadWhen targeted therapy is addedHow the tumour's gene results pick the extra drugTreatment sequence in stage 4 colon cancerWhere conversion fits in the wider stage 4 plan
Talk to us
Could chemotherapy make liver surgery possible for you?
Send us the scans and tumour test results, and the tumour board will review whether conversion is a realistic goal in your situation. One helpline serves every CION centre.